Neurogene has a $903M market cap with two phase 1/2 assets, NGN-401 for Rett Syndrome and NGN-101 for CLN5 Batten Disease.

Cherokees deserve help, treatment and hope – especially those who’ve long felt unseen by the health care system due to their ...

A teenager in British Columbia, Canada, has contracted the H5 strain of bird flu, marking the country's first confirmed human ...

Aaryan Gangar, 11, has successfully overcome a life-threatening ailment of severe rectal bleeding caused by Hermansky-Pudlak ...